Evidence map›Paper›PMID 40066226›Full record

ArticleMedComm2025

Depletion of Acetyl-CoA Carboxylase 1 Facilitates Epithelial-Mesenchymal Transition in Prostate Cancer Cells by Activating the MAPK/ERK Pathway.

Jiarun Lai, Shaoyou Liu, Yupeng Chen, Jian Chen, Jinchuang Li, Zhenguo Liang, Xinyue Mei, Yuanfa Feng, Zhaodong Han, Funeng Jiang and 6 more

Abstract read
In one paragraph

Article in MedComm, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Jiarun LaiGuangdong Provincial Key Laboratory of Urology The First Affiliated Hospital of Guangzhou Medical University Guangzhou China.ORCID https://orcid.org/0009-0008-1886-5156
Shaoyou LiuGuangdong Provincial Key Laboratory of Urology The First Affiliated Hospital of Guangzhou Medical University Guangzhou China.
Yupeng ChenGuangdong Provincial Key Laboratory of Urology The First Affiliated Hospital of Guangzhou Medical University Guangzhou China.
Jian ChenGuangdong Provincial Key Laboratory of Urology The First Affiliated Hospital of Guangzhou Medical University Guangzhou China.
Jinchuang LiGuangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics The Second Affiliated Hospital School of Medicine South China University of Technology Guangzhou China.
Zhenguo LiangGuangdong Provincial Key Laboratory of Urology The First Affiliated Hospital of Guangzhou Medical University Guangzhou China.
Xinyue MeiGuangzhou National Laboratory Guangzhou Guangdong Province China.
Yuanfa FengGuangdong Provincial Key Laboratory of Urology The First Affiliated Hospital of Guangzhou Medical University Guangzhou China.
Zhaodong HanGuangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics The Second Affiliated Hospital School of Medicine South China University of Technology Guangzhou China.
Funeng JiangGuangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics The Second Affiliated Hospital School of Medicine South China University of Technology Guangzhou China.
Shengbang YangGuangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics The Second Affiliated Hospital School of Medicine South China University of Technology Guangzhou China.
Yongding WuGuangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics The Second Affiliated Hospital School of Medicine South China University of Technology Guangzhou China.
Huijing TanGuangdong Key Laboratory of Clinical Molecular Medicine and Diagnostics The Second Affiliated Hospital School of Medicine South China University of Technology Guangzhou China.
Junchen LiuDepartment of Integrative Biology and Pharmacology McGovern Medical School University of Texas Health Science Center Houston Texas USA.
Huichan HeGuangdong Provincial Key Laboratory of Urology The First Affiliated Hospital of Guangzhou Medical University Guangzhou China.
Weide ZhongGuangdong Provincial Key Laboratory of Urology The First Affiliated Hospital of Guangzhou Medical University Guangzhou China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperactivation of fatty acid biosynthesis holds promise as a targeted therapeutic strategy in prostate cancer (PCa). However, inhibiting these enzymes could potentially promote metastatic progression in various other cancers. Herein, we found that depletion of acetyl-CoA carboxylase 1 (encoded by ACACA), the enzyme responsible for the first and rate-limiting step of de novo fatty acid biosynthesis, facilitated epithelial-mesenchymal transition (EMT) and migration of PCa cells. This finding was validated in vitro through cell migration assays and in vivo using a metastatic model established by tail vein injection of ACACA-depleted cells into BALB/c nude mice. Additionally, depletion of ACACA activated the mitogen-activated protein kinase (MAPK)/extracellular signal-regulated protein kinases (ERK) pathway. Inhibition of the MAPK/ERK signaling pathway reduced EMT and migration in ACACA-depleted cells. Our study is the first to indicate targeting ACACA induces an "unexpected" escape program through activation of the MAPK/ERK signaling pathway in PCa, ultimately leading to EMT and metastasis. Therefore, we strongly recommend that the potential adverse effects of targeting ACACA or its derived therapeutic agents must be given extreme attention, especially in MAPK-related cancers.

Indexed as

ACACAEMTfatty acid biosynthesisMAPKmetastasisprostate cancer

Identifiers

PMID40066226
PMCPMC11892147

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.